These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 15475075

  • 1. Establishment and characterization of a new human erythroleukemic cell line, ERY-1.
    Ribadeau Dumas A, Hamouda NB, Leriche L, Piffaut MC, Bonnemye P, Kuen RL, Tricottet V, Merle-Beral H, N'Guyen Khac F, Arock M.
    Leuk Res; 2004 Dec; 28(12):1329-39. PubMed ID: 15475075
    [Abstract] [Full Text] [Related]

  • 2. JAS-R, a new megakaryo-erythroid leukemic cell line that secretes erythropoietin.
    Sekikawa T, Iwase S, Saito S, Arakawa Y, Agawa M, Horiguchi-Yamada J, Yamada H.
    Anticancer Res; 2006 Dec; 26(2A):843-50. PubMed ID: 16619478
    [Abstract] [Full Text] [Related]

  • 3. Establishment and characterization of a new human acute myelocytic leukemia cell line SH-2 with a loss of Y chromosome, a derivative chromosome 16 resulting from an unbalanced translocation between chromosomes 16 and 17, monosomy 17, trisomy 19, and p53 alteration.
    Qiu H, Xue Y, Zhang J, Pan J, Dai H, Wu Y, Wang Y, Chen S, Wu D.
    Exp Hematol; 2008 Nov; 36(11):1487-95. PubMed ID: 18715689
    [Abstract] [Full Text] [Related]

  • 4. New cytokine-dependent acute myeloid leukemia cell line MUTZ-11 with disomic chromosome rearrangement t(16;17).
    Hu ZB, Quentmeier H, Meyer C, Kaufmann M, MacLeod RA, Drexler HG.
    Leuk Res; 2004 May; 28(5):509-15. PubMed ID: 15068904
    [Abstract] [Full Text] [Related]

  • 5. BCR-ABL gene amplification and overexpression in a patient with chronic myeloid leukemia treated with imatinib.
    Gadzicki D, von Neuhoff N, Steinemann D, Just M, Büsche G, Kreipe H, Wilkens L, Schlegelberger B.
    Cancer Genet Cytogenet; 2005 Jun; 159(2):164-7. PubMed ID: 15899391
    [Abstract] [Full Text] [Related]

  • 6. Upregulation of the TGFbeta signalling pathway by Bcr-Abl: implications for haemopoietic cell growth and chronic myeloid leukaemia.
    Møller GM, Frost V, Melo JV, Chantry A.
    FEBS Lett; 2007 Apr 03; 581(7):1329-34. PubMed ID: 17349636
    [Abstract] [Full Text] [Related]

  • 7. [Kinetics of proliferation, differentiation and transcription of genes regulating apoptosis in cultured human BCR/ABL+ Ph+-cells].
    Akhlynina TV, Gerasimova LP, Sarkisian GP, Borovkova TV, Dukhovenskaia EA, Manakova TE, Naĭdenova NM, Timofeev AM, Grineva NI.
    Tsitologiia; 2007 Apr 03; 49(10):889-900. PubMed ID: 18074781
    [Abstract] [Full Text] [Related]

  • 8. Circulating myeloid dendritic cell directly isolated from patients with chronic myelogenous leukemia are functional and carry the bcr-abl translocation.
    Orsini E, Calabrese E, Maggio R, Pasquale A, Nanni M, Trasarti S, Tafuri A, Guarini A, Foa R.
    Leuk Res; 2006 Jul 03; 30(7):785-94. PubMed ID: 16527350
    [Abstract] [Full Text] [Related]

  • 9. c-Jun blocks cell differentiation but not growth inhibition or apoptosis of chronic myelogenous leukemia cells induced by STI571 and by histone deacetylase inhibitors.
    Huang HM, Liu JC.
    J Cell Physiol; 2009 Mar 03; 218(3):568-74. PubMed ID: 19006173
    [Abstract] [Full Text] [Related]

  • 10. [Effects of ST1571 on the development of dendritic cells derived from bone marrow mononuclear cells in patients with chronic myeloid leukemia].
    Zheng SE, Jin J, Tong XM, Qian WB, Xue YQ.
    Zhonghua Zhong Liu Za Zhi; 2006 Dec 03; 28(12):920-3. PubMed ID: 17533744
    [Abstract] [Full Text] [Related]

  • 11. Amplification of BCR-ABL and t(3;21) in a patient with blast crisis of chronic myelogenous leukemia.
    Phan CL, Megat Baharuddin PJ, Chin LP, Zakaria Z, Yegappan S, Sathar J, Tan SM, Purushothaman V, Chang KM.
    Cancer Genet Cytogenet; 2008 Jan 01; 180(1):60-4. PubMed ID: 18068536
    [Abstract] [Full Text] [Related]

  • 12. Chronic lymphocytic leukemia developing in a patient with chronic myeloid leukemia: evidence of distinct lineage-associated genomic events.
    Gargallo P, Cacchione R, Chena C, Dupont J, Garay G, Riveros D, Larripa I, Slavutsky I.
    Cancer Genet Cytogenet; 2005 Aug 01; 161(1):74-7. PubMed ID: 16080961
    [Abstract] [Full Text] [Related]

  • 13. Unique secondary chromosomal abnormalities are frequently found in the chronic phase of chronic myeloid leukemia in southern Vietnam.
    Phan TX, Hoang AV, Huynh VM, Nguyen KT, Nguyen TB, Huynh N, Pham QT, Tran VB, Tran VB, Tokunaga K, Sato Y.
    Cancer Genet Cytogenet; 2006 Jul 01; 168(1):59-68. PubMed ID: 16772122
    [Abstract] [Full Text] [Related]

  • 14. Uncommon karyotypic abnormality, t(11;19)(q23;p13.3), in a patient with blastic phase of chronic myeloid leukemia.
    Suzuki K, Sugawara T, Kowata S, Utsugizawa T, Ito S, Murai K, Ishida Y.
    Cancer Genet Cytogenet; 2004 Apr 15; 150(2):159-63. PubMed ID: 15066325
    [Abstract] [Full Text] [Related]

  • 15. Bcr-Abl expression levels determine the rate of development of resistance to imatinib mesylate in chronic myeloid leukemia.
    Barnes DJ, Palaiologou D, Panousopoulou E, Schultheis B, Yong AS, Wong A, Pattacini L, Goldman JM, Melo JV.
    Cancer Res; 2005 Oct 01; 65(19):8912-9. PubMed ID: 16204063
    [Abstract] [Full Text] [Related]

  • 16. [The application of fluorescence in situ hybridization in detecting chronic myeloid leukemia].
    Qiu HR, Miao KR, Wang R, Qiao C, Zhang JF, Zhang SJ, Qian SX, Xu W, Li JY.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Apr 01; 26(2):207-10. PubMed ID: 19350518
    [Abstract] [Full Text] [Related]

  • 17. No significance of derivative chromosome 9 deletion on the clearance kinetics of BCR/ABL fusion transcripts, cytogenetic or molecular response, loss of response, or treatment failure to imatinib mesylate therapy for chronic myeloid leukemia.
    Kim DH, Popradi G, Sriharsha L, Kamel-Reid S, Chang H, Messner HA, Lipton JH.
    Cancer; 2008 Aug 15; 113(4):772-81. PubMed ID: 18543309
    [Abstract] [Full Text] [Related]

  • 18. Chronic myeloid leukemia with a rare variant BCR-ABL translocation: t(9;22;21)(q34;q11.2;q11.2).
    Takeuchi M, Katayama Y, Okamura A, Yamamoto K, Shimoyama M, Matsui T.
    Cancer Genet Cytogenet; 2007 Nov 15; 179(1):85-7. PubMed ID: 17981222
    [No Abstract] [Full Text] [Related]

  • 19. The biology of chronic myelogenous leukemia: implications for imatinib therapy.
    Alvarez RH, Kantarjian H, Cortes JE.
    Semin Hematol; 2007 Jan 15; 44(1 Suppl 1):S4-14. PubMed ID: 17292736
    [Abstract] [Full Text] [Related]

  • 20. Masked Philadelphia chromosome due to atypical BCR/ABL localization on the 9q34 band and duplication of the der(9) in a case of chronic myelogenous leukemia.
    Fugazza G, Garuti A, Marchelli S, Miglino M, Bruzzone R, Gatti AM, Castello S, Sessarego M.
    Cancer Genet Cytogenet; 2005 Dec 15; 163(2):173-5. PubMed ID: 16337863
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.